By Hanna Vioque (August 15, 2024, 7:22 PM BST) — Samsung’s pharmaceutical unit wants a London judge to nix two patents owned by its rivals that help treat eye disorders, arguing that they are both invalid as it prepares to launch a biosimilar….
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.
